Positive Trial Results For Human Genome

Human Genome Sciences Inc. (Nasdaq: HGSI) announced positive results for its drug candidate in reducing symptoms of lupus. The stock price climbed 52 points to $3.23.

About this Entry

This page contains a single entry by published on June 11, 2009 10:41 AM.

Ameriprise To Raise $900 Million was the previous entry in this blog.

UnitedHealth Downgraded is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12